Moreover, there were no significant differences in positivity of the TDP-43 lesions between the anti-TDP-43 antibodies in the clinical AD/FTD group nor in the FTD group (Additional file 1-Tables A16-A17). This evidence concerns the gene TARDBP and Alzheimer disease.